Apaf1 inhibition promotes cell recovery from apoptosis

[1]  E. Pérez-Payá,et al.  Apaf-1 Inhibitors Protect from Unwanted Cell Death in In Vivo Models of Kidney Ischemia and Chemotherapy Induced Ototoxicity , 2014, PloS one.

[2]  E. Pérez-Payá,et al.  Inactivation of Apaf1 reduces the formation of mutant huntingtin-dependent aggregates and cell death , 2014, Neuroscience.

[3]  E. Pérez-Payá,et al.  Altered Mitochondria Morphology and Cell Metabolism in Apaf1-Deficient Cells , 2014, PloS one.

[4]  E. Pérez-Payá,et al.  BH3-Mimetics- and Cisplatin-Induced Cell Death Proceeds through Different Pathways Depending on the Availability of Death-Related Cellular Components , 2013, PloS one.

[5]  Nektarios Tavernarakis,et al.  Can autophagy promote longevity? , 2010, Nature Cell Biology.

[6]  Jun Chen,et al.  Neuroprotection Against Hypoxic-Ischemic Brain Injury by Inhibiting the Apoptotic Protease Activating Factor-1 Pathway , 2010, Stroke.

[7]  Dirk Brenner,et al.  Mitochondrial cell death effectors. , 2009, Current opinion in cell biology.

[8]  E. Pérez-Payá,et al.  A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury , 2009, PloS one.

[9]  L. Galluzzi,et al.  A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint , 2009, Apoptosis.

[10]  Junying Yuan.  Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke , 2009, Apoptosis.

[11]  H. Tang,et al.  Reversibility of apoptosis in cancer cells , 2008, British Journal of Cancer.

[12]  F. Cecconi,et al.  Apoptosome-deficient cells lose cytochrome c through proteasomal degradation but survive by autophagy-dependent glycolysis. , 2008, Molecular biology of the cell.

[13]  D. Lauffenburger,et al.  Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. , 2008, Molecular cell.

[14]  E. Pérez-Payá,et al.  Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors. , 2008, Journal of medicinal chemistry.

[15]  Pascal Barbry,et al.  GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase Activation , 2007, Cell.

[16]  G. Takemura,et al.  Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. , 2007, Progress in cardiovascular diseases.

[17]  E. Pérez-Payá,et al.  Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis , 2006, Cell Death and Differentiation.

[18]  S. Fulda,et al.  Apoptosis and Cancer Therapy , 2006 .

[19]  S. Linton.  Caspase inhibitors: a pharmaceutical industry perspective. , 2005, Current topics in medicinal chemistry.

[20]  D. Green,et al.  Pharmacological manipulation of cell death: clinical applications in sight? , 2005, The Journal of clinical investigation.

[21]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[22]  Philippe Dessen,et al.  Inhibition of Macroautophagy Triggers Apoptosis , 2005, Molecular and Cellular Biology.

[23]  A. Yamamoto,et al.  LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation , 2004, Journal of Cell Science.

[24]  N. Hoglen,et al.  Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[25]  Markus Rehm,et al.  Real-time single cell analysis of Smac/DIABLO release during apoptosis , 2003, The Journal of cell biology.

[26]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[27]  G. Cohen,et al.  Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro * , 2002, The Journal of Biological Chemistry.

[28]  K. Tamayose,et al.  An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Horvitz,et al.  Phagocytosis promotes programmed cell death in C. elegans , 2001, Nature.

[30]  Daniel J. Hoeppner,et al.  Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans , 2001, Nature.

[31]  T. Mak,et al.  Caspase-independent cell death and mitochondrial disruptions observed in the Apaf1-deficient cells. , 2001, Journal of biochemistry.

[32]  J. Dichgans,et al.  Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6‐hydroxydopamine‐induced apoptosis but not against the loss of their terminals , 2001, Journal of neurochemistry.

[33]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[34]  Eugene M. Johnson,et al.  Caspase Inhibition Extends the Commitment to Neuronal Death Beyond Cytochrome c Release to the Point of Mitochondrial Depolarization , 2000, The Journal of cell biology.

[35]  K. Maehara,et al.  Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. , 2000, Cardiovascular research.

[36]  P. Knapp,et al.  Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury , 1999, Nature Medicine.

[37]  J. Martinou,et al.  The Release of Cytochrome c from Mitochondria during Apoptosis of NGF-deprived Sympathetic Neurons Is a Reversible Event , 1999, The Journal of cell biology.

[38]  P. Vandenabeele,et al.  Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.

[39]  S. Srinivasula,et al.  Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. , 1998, Molecular cell.

[40]  A. Shah,et al.  Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. , 1998, The Journal of clinical investigation.

[41]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[42]  A. Bacci,et al.  Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease , 2011, Nature Neuroscience.

[43]  M. Peter,et al.  The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.

[44]  H. Fearnhead.  Cell-free systems to study apoptosis. , 2001, Methods in Cell Biology.

[45]  C. V. van Noorden.  The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. , 2001, Acta histochemica.

[46]  H. Fearnhead.  Chapter 7 Cell-free systems to study apoptosis , 2001 .

[47]  M. Leist,et al.  ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. , 1997, Immunology letters.